Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

By Christoph U. Correll, J. Detraux, J. de Lepeleire, M. De Hert. World Psychiatry, 2015

777 citations recorded by the source corpus.

Subfields: Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/1f6d18cfb9ddd493efa98a74dc182c78ef459d1b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Psychiatry and Mental health

1. Brendon Stubbs
2. Christoph U. Correll
3. A. Mitchell

Citations in the corpus

• Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016, background): “Thus, other diagnostic-independent factors likely influence T2DM frequency, including hyperglycaemia following psychotropic medication use (26) and long-term”
• Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015, result): “For example, previous studies (52) found that some antidepressants may, in some circumstances, reduce hyperglycaemia, normalize glucose homeostasis and also increase insulin sensitivity, whereas others, including tricyclic antidepressants, may exacerbate glycaemic dysfunction or have little effect o”